The impact of environmental pollution on fertility has become an essential issue in global public health. Maturation, fertilisation, and embryonic development of oocytes depend on the energy provided by mitochondria; however, with increased environmental pollution and ageing, mitochondrial dysfunction and its subsequent functional and metabolic abnormalities have become leading causes of female fertility decline. When mitochondrial dysfunction occurs in the oocyte, reduced metabolic efficiency leads to impaired nuclear and cytoplasmic maturation of the oocyte, affecting the quality of the oocyte, which further contributes to decreased female fertility and increased risk of infertility, miscarriage, and aneuploid foetuses due to ovarian dysfunction. Several factors affect mitochondrial function, including excess reactive oxygen species (ROS)-induced mutations in mitochondrial DNA (mtDNA), changes in mtDNA copy number, oxidative stress (OS), damage to key cellular components and organelles, and changes in metabolic intermediates and byproducts at the cellular level, further affecting oocyte developmental competence. Mitochondrial dysfunction leads to problems such as abnormal spindle formation and chromosome misalignment, reducing fertilisation potential and embryonic developmental capacity. Mitochondrial dysfunction plays a key role in oocyte ageing and the decline in germ cell function, and an in-depth study of its molecular mechanisms and intervention strategies is highly important for slowing oocyte ageing, increasing fertility, and improving the success rate of assisted reproduction techniques. Clinical trial number Not applicable.
Alcohol induces neurodevelopmental toxicity through multiple biological processes, including DNA methylation and histone modifications in epigenetic regulation. Epigenetic mechanisms involving DNA chemical modifications represent crucial molecular pathways that regulate gene expression during neurodevelopment, exhibiting high sensitivity to adverse lifestyle factors such as alcohol consumption, smoking, and stress. Prenatal alcohol consumption is a primary cause of fetal neurodevelopmental disorders. Alcohol alters DNA methylation and histone modification levels in the brain, which in turn disrupts the expression levels of related genes. This review focuses on how alcohol mediates neurodevelopmental toxicity by disrupting DNA methylation mechanisms. First, alcohol affects DNA methylation through the following pathways: (1) Inhibiting folate metabolism reduces the production of the methyl donor S-adenosylmethionine (SAM), thereby decreasing DNA methyltransferase (DNMTs) activity; (2) Induces oxidative stress, where reactive oxygen species (ROS) disrupt methylation status at CpG sites; (3) Directly alters the activity of DNMTs and TETs, leading to hypermethylation or hypomethylation in gene promoter regions. These abnormal methylation patterns significantly impact the differentiation neural stem cells (NSCs), neuronal migration and synapse formation, as well as the function of glial cells. Methylation abnormalities in neurodevelopment-related genes can trigger neuronal migration defects and synaptic plasticity disorders. Alcohol-induced methylation-related changes exhibit brain region specificity, involving areas such as the hippocampus, prefrontal cortex, and hypothalamus. Regarding intervention strategies, prenatal supplementation with methyl donors like folate and choline partially reverses alcohol-induced abnormal DNA methylation and improves neurodevelopmental outcomes. This study highlights the role of DNA methylation in alcohol-mediated neurotoxicity, providing a theoretical basis for elucidating the molecular mechanisms of FASD and developing targeted epigenetic therapeutic strategies.
Reasons for the decrease in fertility, including physical health problems caused by unhealthy lifestyles, late marriage, reproductive aging, etc. Among them female reproductive aging, which is gradually being emphasized, because the ovary is the source of maintaining female fertility and is a major supplier of endocrine homeostatic hormones [2]. It stores primordial follicles, which contain oocytes and their associated somatic cells. Primordial follicles are produced in the female fetus and do not appear to be replenished after birth [3]. Therefore, we focus on ovarian aging, including Premature Ovarian Failure (POF) and Natural Ovarian Aging (NOA). Conventional solutions such as hormone replacement therapy and antioxidants, while providing some relief, often have limited effects and may cause side effects [4, 5]. Therefore, it has
Although 70% of patients with estrogen receptor‑positive breast cancer benefit from tamoxifen (TAM) therapy, the development of resistance to TAM leads to high rates of metastasis and a poor prognosis. Propofol, a commonly used anesthetic, can inhibit the occurrence and progression of breast cancer. In the present study, the effects of propofol on TAM‑resistant (TR) breast cancer cells were evaluated. MCF7‑TR cells were treated with or without propofol. Subsequently, cell cycle progression and the induction of apoptosis were detected by flow cytometry, whereas cell proliferation was assessed using Cell Counting Kit‑8 and colony formation assays. Furthermore, the potential transcriptional regulatory effects of propofol on MCF7‑TR cells were investigated using RNA sequencing. The results indicated that propofol significantly promoted cell cycle arrest, induced apoptosis, and inhibited proliferation and colony formation in MCF7‑TR cells. Furthermore, transcriptome sequencing analysis revealed 1,065 differentially expressed genes between propofol‑treated MCF7‑TR and untreated MCF7‑TR cells. Gene Ontology annotation enrichment analysis, Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis and Gene Set Enrichment Analysis indicated that propofol affected the expression levels of genes located on the ‘plasma membrane’ and ‘cell periphery’, while mainly regulating signals involved in cancer biology, immune response and metabolic pathways. These results identified the potential effects of propofol on TR breast cancer cells and provided a theoretical basis for clinical treatment, particularly for individuals with TAM resistance.
Backgrounds: Osimertinib resistance in Non-Small-Cell Lung Cancers (NSCLC) is a difficult problem to be solved in clinic. Formononetin is one of the main isoflavone components, which has strong anti-cancer effects in NSCLC. However, the potential effects and the mechanisms of Formononetin to counteract the Osimertinib resistant in NSCLC is remain to be uncovered. Methods: Osimertinib-resistant NSCLC cell line (H1975_OR) was generated by increasingly adding of Osimertinib in H1975 cell culture medium. The Formononetin was used to induce H1975_OR cell apoptosis an to inhibit cell proliferation and clonal formation. The RNA-sequencing was used to study the potential mechanisms for Formononetin to counteract the Osimertinib resistant in NSCLC. Results: Formononetin could significantly induced cell apoptosis, whereas, dramatically inhibited cell proliferation and clinal formation in H1975_OR cells. Formononetin induced tremendous alterations of gene expression in H1975_OR cells and these genes can be clustered into unique GO, KEGG and GSEA pathways. Conclusion: Our results preliminarily uncovered the underlying mechanisms for Formononetin counteracted Osimertinib-resistance in NSCLC cells and provided a potential treatment method for Osimertinib resistant NSCLC patients.
Although 70% of estrogen receptor (ER)-positive breast cancer patients benefit from Tamoxifen therapy, the developing resistance to Tamoxifen leads to high rates of metastasis and poor prognosis. Propofol, a commonly used anesthetic, has been shown to inhibit the occurrence and development of breast cancer. However, its role in anti-endocrine resistance in ER-positive breast cancer remains unclear. In this study, we found that Propofol significantly promotes cell cycle arrest, induces apoptosis, and inhibits proliferation in Tamoxifen-resistant breast cancer cells. Furthermore, transcriptome sequencing analysis revealed 1065 differentially expressed genes (DEGs) between Propofol-treated Tamoxifen-resistant MCF-7 (MCF7-TR) cells and none-treated MCF7-TR cells. Gene ontology annotation enrichment analysis (GO), Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis (KEGG), and gene set enrichment analysis (GSEA) showed that Propofol affects the expression of genes located in the plasma membrane and cell periphery, mainly regulating signals involved in cell cycle regulation, immune response modulation, and metabolism. Our results provide new insights into the mechanism by which Propofol controls resistance to Tamoxifen in breast cancer progression and offer a theoretical basis for clinical treatment.